Optiver Holding
MRVI icon

Optiver Holding’s Maravai LifeSciences MRVI Stock Holding History

Optiver Holding’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.23K Buy
788
+208
+36% +$705 ﹤0.01% 1798
2025
Q4 		$1.89K Sell
580
-1,278
-69% -$4.3K ﹤0.01% 2047
2025
Q3 		$5.33K Buy
+1,858
New +$4.74K ﹤0.01% 1695

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Optiver Holding's MRVI Position: Q1 2026 in Review

Optiver Holding increased its Maravai LifeSciences (MRVI) stake by 36% in Q1 2026, buying an estimated $705 and bringing the position to 788 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1798.

Optiver Holding first reported a position in MRVI in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.33K in Q3 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Optiver Holding held 788 shares of Maravai LifeSciences worth $2.23K as of Q1 2026.
  • Optiver Holding bought 208 Maravai LifeSciences shares in Q1 2026, an estimated $705.
  • Maravai LifeSciences made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1798 holding.
  • Optiver Holding first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Maravai LifeSciences position peaked at $5.33K in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.